Bozic Carmen — SEC Form 4 filings
SEC reporting owner CIK 1790029. 31 Form 4 filings on record with FilingPulse; latest filed 2026-06-30.
Transaction summary — filings shown
Covers all 31 filings on record, filed 2024-02-08 to 2026-06-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 16 filings — 38,406 shares, $17,803,051 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 6,988 shares @ $450.00 ($3,144,600) in VERTEX PHARMACEUTICALS INC / MA, filed 2026-05-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP and CMO | 31 | — | 16 legs · 38,406 sh · $17,803,051 | 21 |
Form 4 filings — Bozic Carmen
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-30 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 596 @ $482.50 | EDGAR |
| 2026-06-23 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 1,020 @ $462.17 | EDGAR |
| 2026-06-17 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 4,062 @ $450 | EDGAR |
| 2026-06-09 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 1,745 @ $450 | EDGAR |
| 2026-06-02 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 1,974 @ $450 | EDGAR |
| 2026-05-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 1,354 @ $453.45 | EDGAR |
| 2026-05-14 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 6,988 @ $450 | EDGAR |
| 2026-03-31 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 2,329 @ $450.95 | EDGAR |
| 2026-03-17 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 2,329 @ $481.79 | EDGAR |
| 2026-03-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 2,329 @ $480.31 | EDGAR |
| 2026-02-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 1,453 @ $485.11 | EDGAR |
| 2026-02-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 5,375 @ $0 · Tax withholding (F): 1,912 @ $483.75 | EDGAR |
| 2026-02-18 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,804 @ $487.76 | EDGAR |
| 2026-02-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,145 @ $468.41 | EDGAR |
| 2026-01-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 7,866 @ $0 · Grant/award (A): 3,467 @ $0 | EDGAR |
| 2025-02-28 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 4,962 @ $479.61 | EDGAR |
| 2025-02-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,310 @ $483.28 | EDGAR |
| 2025-02-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 1,912 @ $463.46 | EDGAR |
| 2025-02-14 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 5,546 @ $0 | EDGAR |
| 2025-02-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,142 @ $467.98 | EDGAR |
| 2025-02-06 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 10,262 @ $0 · Grant/award (A): 5,928 @ $0 | EDGAR |
| 2024-08-08 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 2,280 @ $476.75 | EDGAR |
| 2024-07-25 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 2,280 @ $488.46 | EDGAR |
| 2024-07-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 2,280 @ $487.34 | EDGAR |
| 2024-06-28 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 2,280 @ $471.72 | EDGAR |
| 2024-06-13 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 2,280 @ $478 | EDGAR |
| 2024-05-31 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 2,280 @ $445.56 | EDGAR |
| 2024-02-27 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,309 @ $431.79 | EDGAR |
| 2024-02-21 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,750 @ $424.01 · Tax withholding (F): 2,812 @ $420.58 | EDGAR |
| 2024-02-13 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,100 @ $422.74 | EDGAR |
| 2024-02-08 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 5,814 @ $0 · Grant/award (A): 7,866 @ $0 · Grant/award (A): 5,928 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1790029 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →